NYSE:HIMSHealthcare
Hims & Hers Health (NYSE:HIMS) Sees 95% Price Jump Despite Sector Concerns Over Medicare Scrutiny
Hims & Hers Health (NYSE:HIMS) saw a remarkable share price increase of 95% over the last quarter, amid a broader market context that witnessed significant declines. Unlike the plunge in major indexes during February, particularly the 2% fall in the Nasdaq Composite, HIMS's performance was buoyed by positive company developments and possibly broader consumer health trends. While UnitedHealth and other insurers faced scrutiny from the Department of Justice regarding Medicare billing practices,...